Overview Fundamentals API Earnings EOD API Sample Code Pricing

Adaptive Biotechnologies Corp (ADPT NASDAQ) stock market data APIs

$4.22 0.18(4.5%) as of July 19, 2024
Price chart is built with Anychart

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Adaptive Biotechnologies Corp Financial Data Overview

595 M
147 M
175 M
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ADPT',
Type: 'Common Stock',
Name: 'Adaptive Biotechnologies Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001J2PFF5',
CIK: '1478320',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-06-27',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Adaptive Biotechnologies Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 175 M
  • EBITDA -171 152 992
  • Earnings Per Share -1.49
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Adaptive Biotechnologies Corp Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -0.34

Get Adaptive Biotechnologies Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?